Annual financial news and ad hoc releases
In our archive you will find financial news since 2005
Offenburg, April 12, 2012 – The Supervisory Board of MEDICLIN Aktiengesellschaft (MediClin) decided to propose to the General Annual Meeting, taking place on May 23, 2012, to elect Dr. Jochen Messemer, Stephan Leonhard and Dr. Ulrich Wandschneider to the supervisory board.
Dr. Jochen Messemer runs for re-election after expiration of his mandate. Stephan Leonhard was appointed by the court and should be elected by the General Annual Meeting. Dr. Ulrich Wandschneider is recommended by the majority shareholder Asklepios Kliniken Gesellschaft mit beschränkter Haftung, Hamburg, to be elected to the supervisory board, after Dr. Jan Boetius, supervisory board member and chairman of the supervisory board has resigned as of May 31, 2012. The Supervisory Board has also decided to propose Dr. Ulrich Wandschneider as candidate to become chairman of the supervisory board, if elected to the supervisory board, based on his industry experience for many years and in view of his function as Chairman of Corporate Management of the Asklepios-Group.
Dr. Ulrich Wandschneider has resigned as Board Member of the Management Board of MediClin as of May 31, 2012.
Jens Breuer, future CFO of MediClin, will take office already as of June 1st, 2012.
About MediClin AG (Ticker: MED; WKN: 659 510)
MediClin AG is a nation-wide clinic operator and large provider of services in the area of Psycho- and Neuro-sciences as well as Orthopaedic. With 34 clinics and 7 nursing care facilities and 11 Medizinische Versorgungszentren (medical care units) in 11 federal states MediClin has a total capacity of approximately 8,100 beds. MediClins’ facilities include acute care clinics, i.e., general hospitals, special treatment facilities, specialised hospitals and clinics for post-acute treatment and medical rehabilitation. MediClin has approximately 8,300 employees.